Fred D. Lublin, MD
Dr. Fred D. Lublin is the Saunders Family Professor of Neurology and Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at The Icahn School of Medicine at Mount Sinai in New York, New York.
As a neuroimmunologist, Dr. Lublin has a special interest in immune functions and abnormalities affecting the nervous system. He and his colleagues were among the first in the country involved with studies of interferon β-1b, which was approved by the US Food and Drug Administration in 1993 to treat the relapsing-remitting form of multiple sclerosis (MS). He is the principal investigator of the National Institutes of Health–sponsored multicenter combination therapy study in multiple sclerosis. . He is a member of the National MS Society National Board of Directors and an immediate past chair of the New York City/Southern New York Chapter of NMSS Clinical Advisory Committee. He is a member of the International Medical and Scientific Board of the MS International Federation. Dr. Lublin and his colleagues at the National MS Society re-defined the clinical course definitions of MS, updated in 2014. Dr. Lublin is a member of the international panel that periodically redefines the diagnostic criteria for MS. Dr. Lublin is co-chair of the National Institute of Neurological Diseases and Stroke MS Common Data Element committee and a member of their steering committee. He is a member of the WHO Advisory Group for the Revision of ICD-10 Diseases of the Nervous System working group on demyelinating diseases of the CNS. He is a co-chief editor of Multiple Sclerosis and Related Disorders.
Dr. Lublin has published numerous scientific articles and has served as a consultant to the National Institutes of Health and many pharmaceutical/biotech companies
Dr. Lublin earned an MD degree from Jefferson Medical College in Philadelphia, Pennsylvania. He completed an internship in internal medicine at the Bronx Municipal Hospital, Albert Einstein Medical Center, and a residency at the New York Hospital, Cornell Medical Center.